Obesity Medicine

Anti-Obesity Drugs

Pharmacological therapy plays a critical role in managing obesity, especially for individuals who struggle with lifestyle interventions alone. Anti-obesity drugs target various pathways involved in appetite regulation, energy expenditure, and nutrient absorption. Commonly used medications include appetite suppressants, lipase inhibitors, and metabolic enhancers, each with specific mechanisms and indications. Drugs such as orlistat reduce fat absorption, while agents like GLP-1 receptor agonists regulate appetite and improve insulin sensitivity. Pharmacotherapy is often combined with lifestyle modifications, including dietary adjustments, increased physical activity, and behavioral therapy, to maximize effectiveness. Proper patient selection, dose titration, and monitoring for adverse effects are essential to ensure safety and efficacy. Ongoing research explores novel pharmacological agents, combination therapies, and personalized medicine approaches based on genetic and metabolic profiles. Anti-obesity drugs can significantly improve weight loss outcomes, reduce comorbidities such as diabetes and cardiovascular diseases, and enhance quality of life. Clinicians must consider individual patient needs, comorbid conditions, and long-term adherence when prescribing pharmacotherapy for obesity management.